Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora L Swart

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
European Journal of Clinical Pharmacology|June 4, 2020
Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinibChristel C L M Boons, Lonneke Timmers, Jeroen J W M Janssen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 4, 2023
Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19Nadia Baalbaki, Erik Duijvelaar, Medhat M Said, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 5, 2021
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib studyImke H Bartelink, Pierre M Bet, Nicolas Widmer, et al.
Trials|December 20, 2019
Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock - rationale and design of a multicenter randomized controlled superiority trialLuca F Roggeveen, Lucas M Fleuren, Tingjie Guo, et al.
Regional Anesthesia and Pain Medicine|January 14, 2022
ED90 of spinal 2-chloroprocaine 1% in ambulatory knee arthroscopy up to 45 min: a randomized biased-coin- up-and-down sequential allocation trialElsbeth J Wesselink, Seppe J Koopman, Rien van der Vegt, et al.
The Journal of Climate Change and Health|February 6, 2026
Unused medication: mapping the impact across the Dutch healthcare systemRou Qing Chen, Elisabeth M Smale, Patricia M L A van den Bemt, et al.
Critical Care (London, England)|September 5, 2022
Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trialLuca F Roggeveen, Tingjie Guo, Lucas M Fleuren, et al.
British Journal of Clinical Pharmacology|October 27, 2017
Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failureJanneke M Brussee, Nienke J Vet, Elke H J Krekels, et al.
Thrombosis Research|February 20, 2024
Smaller nadroparin dose reductions required for patients with renal impairment: A multicenter cohort studyRenate C A E van Uden, Tessa C C Jaspers, Karina Meijer, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
European Journal of Clinical Pharmacology|June 4, 2020
Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinibChristel C L M Boons, Lonneke Timmers, Jeroen J W M Janssen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 4, 2023
Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19Nadia Baalbaki, Erik Duijvelaar, Medhat M Said, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 5, 2021
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib studyImke H Bartelink, Pierre M Bet, Nicolas Widmer, et al.
Trials|December 20, 2019
Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock - rationale and design of a multicenter randomized controlled superiority trialLuca F Roggeveen, Lucas M Fleuren, Tingjie Guo, et al.
Regional Anesthesia and Pain Medicine|January 14, 2022
ED90 of spinal 2-chloroprocaine 1% in ambulatory knee arthroscopy up to 45 min: a randomized biased-coin- up-and-down sequential allocation trialElsbeth J Wesselink, Seppe J Koopman, Rien van der Vegt, et al.
The Journal of Climate Change and Health|February 6, 2026
Unused medication: mapping the impact across the Dutch healthcare systemRou Qing Chen, Elisabeth M Smale, Patricia M L A van den Bemt, et al.
Critical Care (London, England)|September 5, 2022
Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trialLuca F Roggeveen, Tingjie Guo, Lucas M Fleuren, et al.
British Journal of Clinical Pharmacology|October 27, 2017
Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failureJanneke M Brussee, Nienke J Vet, Elke H J Krekels, et al.
Thrombosis Research|February 20, 2024
Smaller nadroparin dose reductions required for patients with renal impairment: A multicenter cohort studyRenate C A E van Uden, Tessa C C Jaspers, Karina Meijer, et al.
Pageof 7